Abstract
Mammary lipoenxertia and the use of adipose tissue derived stem cells (ADSC) for the treatment of breast disorders result in an oncological treatment, currently an important therapeutic arsenal that has not yet been explored. Many obstacles of scientific communication in theoretical concepts and in preclinical studies with limiting biases have exerted limited importance in their improveme…